Amedisys, Inc. (NASDAQ:AMED) Shares Bought by Gotham Asset Management LLC

Gotham Asset Management LLC increased its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 77.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 246,918 shares of the health services provider's stock after buying an additional 107,720 shares during the period. Gotham Asset Management LLC owned about 0.75% of Amedisys worth $22,418,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Barclays PLC raised its position in shares of Amedisys by 49.5% in the 3rd quarter. Barclays PLC now owns 15,529 shares of the health services provider's stock worth $1,500,000 after buying an additional 5,142 shares during the period. HBW Advisory Services LLC bought a new stake in shares of Amedisys in the 4th quarter worth approximately $38,000. Oak Thistle LLC lifted its stake in shares of Amedisys by 97.6% in the 4th quarter. Oak Thistle LLC now owns 6,964 shares of the health services provider's stock worth $632,000 after acquiring an additional 3,440 shares during the period. Ballentine Partners LLC acquired a new position in shares of Amedisys in the 4th quarter worth approximately $334,000. Finally, Nisa Investment Advisors LLC increased its position in shares of Amedisys by 1.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider's stock worth $1,375,000 after acquiring an additional 180 shares in the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Stephens reaffirmed an "equal weight" rating and set a $101.00 price objective on shares of Amedisys in a research report on Tuesday, March 4th. Royal Bank of Canada restated an "outperform" rating and set a $100.00 price target on shares of Amedisys in a research note on Wednesday, April 16th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $100.75.

Amedisys Stock Performance

Shares of AMED traded down $0.67 during mid-day trading on Tuesday, reaching $94.75. The company's stock had a trading volume of 54,528 shares, compared to its average volume of 413,780. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 1-year low of $82.15 and a 1-year high of $98.95. The stock has a market cap of $3.11 billion, a P/E ratio of 37.60, a PEG ratio of 1.78 and a beta of 0.96. The business has a 50-day simple moving average of $93.04 and a two-hundred day simple moving average of $91.64.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. During the same quarter in the previous year, the company earned $1.03 earnings per share. Amedisys's quarterly revenue was up 4.1% on a year-over-year basis. As a group, equities research analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.